Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Quantifying the RSV immunity debt following COVID-19: a public health matter
Marie‐Noëlle Billard, Louis Bont
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 1, pp. 3-5
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Respiratory syncytial virus infection and novel interventions
Annefleur C. Langedijk, Louis Bont
Nature Reviews Microbiology (2023) Vol. 21, Iss. 11, pp. 734-749
Closed Access | Times Cited: 80
Changing patterns of infectious diseases in children during the COVID-19 pandemic
Ming‐Chun Yang, Yu‐Tsun Su, Ping-Hong Chen, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 45
Increased Pediatric Respiratory Syncytial Virus Case Counts Following the Emergence of SARS-CoV-2 Can Be Attributed to Changes in Testing
Brittany A. Petros, Carly E. Milliren, Pardis C. Sabeti, et al.
Clinical Infectious Diseases (2024) Vol. 78, Iss. 6, pp. 1707-1717
Open Access | Times Cited: 17
Postpandemic immunity debt of influenza in the USA and England: an interrupted time series study
Char Leung, László Kónya, Li Su
Public Health (2024) Vol. 227, pp. 239-242
Open Access | Times Cited: 14
Characterising the changes in RSV epidemiology in Beijing, China during 2015–2023: results from a prospective, multi-centre, hospital-based surveillance and serology study
Maozhong Li, Bingbing Cong, Xiaofeng Wei, et al.
The Lancet Regional Health - Western Pacific (2024) Vol. 45, pp. 101050-101050
Open Access | Times Cited: 14
Decline of RSV-specific antibodies during the COVID-19 pandemic
Gerco den Hartog, Puck B. van Kasteren, Rutger M. Schepp, et al.
The Lancet Infectious Diseases (2022) Vol. 23, Iss. 1, pp. 23-25
Open Access | Times Cited: 55
Association of COVID-19 with respiratory syncytial virus (RSV) infections in children aged 0–5 years in the USA in 2022: a multicentre retrospective cohort study
Lindsey Wang, Pamela B. Davis, Nathan A. Berger, et al.
Family Medicine and Community Health (2023) Vol. 11, Iss. 4, pp. e002456-e002456
Open Access | Times Cited: 22
Clinical, Genomic, and Immunological Characterization of RSV Surge in Sydney, Australia, 2022
Gregory J. Walker, Charles S. P. Foster, Andrea Sevendal, et al.
PEDIATRICS (2024)
Open Access | Times Cited: 11
Pediatric Respiratory Syncytial Virus Hospitalizations, 2017-2023
Tiffany Fitzpatrick, Sarah A. Buchan, Sanjay Mahant, et al.
JAMA Network Open (2024) Vol. 7, Iss. 6, pp. e2416077-e2416077
Open Access | Times Cited: 10
Global patterns of rebound to normal RSV dynamics following COVID-19 suppression
Deus Thindwa, Ke Li, Dominic Cooper-Wootton, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 10
Resurgence of Respiratory Syncytial Virus in the Summer of 2021 in Denmark—a Large out-of-season Epidemic Affecting Older Children
Frederikke Kristensen Lomholt, Hanne‐Dorthe Emborg, Sarah Kristine Nørgaard, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 3
Open Access | Times Cited: 9
Impact of Nonpharmaceutical Interventions during the COVID-19 Pandemic on the Prevalence of Respiratory Syncytial Virus in Hospitalized Children with Lower Respiratory Tract Infections: A Systematic Review and Meta-Analysis
José J. Leija-Martínez, Luis A. Esparza-Miranda, Gerardo Rivera-Alfaro, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 429-429
Open Access | Times Cited: 8
Respiratory syncytial virus knowledge, attitudes, and perceptions among adults in the United States
Elizabeth M. La, Su Bunniran, Diana Garbinsky, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 7
Recent Progress toward the Discovery of Small Molecules as Novel Anti-Respiratory Syncytial Virus Agents
Tommaso Felicetti, Chiara Sarnari, Roberta Gaito, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 7
Time trend and seasonality in medically attended respiratory syncytial virus (RSV) infections in US children aged 0–5 years, January 2010–January 2023
Lindsey Wang, Nathan A. Berger, Pamela B. Davis, et al.
Family Medicine and Community Health (2023) Vol. 11, Iss. 4, pp. e002453-e002453
Open Access | Times Cited: 17
Year-Round Respiratory Syncytial Virus Transmission in The Netherlands Following the COVID-19 Pandemic: A Prospective Nationwide Observational and Modeling Study
Yvette N. Löwensteyn, Zhe Zheng, Neele Rave, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 10, pp. 1394-1399
Closed Access | Times Cited: 16
Seasonality of respiratory syncytial virus infection in children hospitalized with acute lower respiratory tract infections in Hunan, China, 2013–2022
Le‐Yun Xie, Tao Wang, Yu Tian, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 6
Pediatric Respiratory Syncytial Virus Hospitalizations and Respiratory Support After the COVID-19 Pandemic
Zachary A. Winthrop, Jennifer M. Perez, Steven J. Staffa, et al.
JAMA Network Open (2024) Vol. 7, Iss. 6, pp. e2416852-e2416852
Open Access | Times Cited: 6
Increased pediatric RSV case counts following the emergence of SARS-CoV-2 are attributable to increased testing
Brittany A. Petros, Carly E. Milliren, Pardis C. Sabeti, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Verification of Immune Debts in Children Caused by the COVID-19 Pandemic from an Epidemiological and Clinical Perspective
Masayuki Nagasawa
Immuno (2025) Vol. 5, Iss. 1, pp. 5-5
Open Access
Impact of the passive immunization campaign with nirsevimab in 2023–24 in Castellón. Final results
Eulalia Gregori-García, Juan Carlos Gascó-Laborda, Lledó Lluch-Bacas, et al.
Enfermedades infecciosas y microbiologia clinica (English ed ) (2025)
Closed Access
Epidemiological Changes in Hospitalized Bronchiolitis in Children Under 2 Years of Age in Hangzhou Before and After COVID-19 Restriction Easing
Xuchen Xu, Xiya Chen, Jing He, et al.
Infection and Drug Resistance (2025) Vol. Volume 18, pp. 835-845
Open Access
Rebound of Antibiotic Use and Respiratory Infections After Resumption of Normalcy From COVID-19 in Hong Kong
Edmond Siu-Keung, Enoch Hsu, Vincent Chow, et al.
Infection and Drug Resistance (2025) Vol. Volume 18, pp. 1325-1337
Open Access
Recent trends in hospitalizations for Respiratory Syncytial Virus after the COVID-19 pandemic and before routine immunization: seasonality and severity updates from the 2023/2024 season in Tuscany, Italy
Vieri Lastrucci, Martina Pacifici, Monia Puglia, et al.
International Journal of Infectious Diseases (2025), pp. 107879-107879
Open Access
High bacterial coinfection rates and associated mortality among hospitalized older adults with laboratory-confirmed respiratory syncytial virus infection
Yuchang Fu, Ting‐Wei Lai, Yuhua Su, et al.
Journal of Microbiology Immunology and Infection (2025)
Open Access
Page 1 - Next Page

Scroll to top